Literature DB >> 22784247

Long-term results and complications of the syringopleural shunting for treatment of syringomyelia: a clinical study.

Nejat Isik1, Ilhan Elmaci, Nihal Isik, S Ajlan Cerci, Recep Basaran, Melek Gura, Mufit Kalelioglu.   

Abstract

BACKGROUND: The use of drains in the treatment of syringomyelia has a simple and immediate appeal. Syringopleural shunting in syringomyelia has produced good short-term results, but limited information is available on long-term effects. We analyzed the complications and long-term outcomes after syringopleural shunting for syringomyelia. CLINICAL
MATERIAL AND METHODS: Fourthy-four patients with large-sized syringomyelia underwent syringopleural shunting because of spinal cord compression between 1992 and 2010 in our clinic. Thirty-two patients had Chiari malformation type I (Group B), and 12 patients were associated with primary parenchymal cavitations (Group A). Their ages ranged from 14 to 71 years. Both craniovertebral decompression and syringopleural shunting were performed on 21 patients, whereas only syringopleural shunting was performed on another 21 patients.
RESULTS: The follow-up period ranged from 1 year to 17 years (mean: 9.1 years). There was no operative mortality. Early postoperative MRI revealed that syringes of 43 patients had collapsed. There were 9 (20.5%) minor complications in 9 patients, including temporary neurological deficits (6), respiratory distress (2) and headache (1). Seven (15.9%) serious complications [permanent neurological deficit (1), shunt migration (2), shunt misplacement (1), spinal instability (1), tethering (1), CSF over drainage (1)] were seen in five patients. Four of them were treated with a secondary operation. Three patients (3/9; 33.3%) who were treated by syringopleural shunt alone (Group B2) required craniovertebral decompression, although the shunt was functional. During long-term follow-up, three patients stabilized, five patients (11.3%) developed a worse neurological condition, and two of these patients died 10 and 7 years after surgery. Of all patients, 88.6% showed significant clinical improvement.
CONCLUSIONS: Although there were complications and failures, syringopleural shunting produced satisfactory results at long-term follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 22784247     DOI: 10.3109/02688697.2012.703350

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  7 in total

1.  Recurrent symptomatic pleural effusion from a syringopleural shunt.

Authors:  Crystal T Ajja; Tiffany F Chang; Eric Ayers
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-01-22

2.  Direct syrinx drainage in patients with Chiari I malformation.

Authors:  Jehuda Soleman; Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2019-06-01       Impact factor: 1.475

3.  Pediatric Chiari malformation type I: long-term outcomes following small-bone-window posterior fossa decompression with autologous-fascia duraplasty.

Authors:  Hai Liu; Chenlong Yang; Jun Yang; Yulun Xu
Journal:  Exp Ther Med       Date:  2017-09-27       Impact factor: 2.447

4.  Intracranial hypotension after syringopleural shunting in posttraumatic syringomyelia: Case report and review of the literature.

Authors:  Johanne C Summers; Yagnesh Vellore; Patrick C H Chan; Jeffrey V Rosenfeld
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

5.  Treatment of Posttubercular Syringomyelia Not Responsive to Antitubercular Therapy: Case Report and Review of Literature.

Authors:  Giuseppe Canova; Alessandro Boaro; Enrico Giordan; Pierluigi Longatti
Journal:  J Neurol Surg Rep       Date:  2017-04

6.  Treatment of posttraumatic syringomyelia: evidence from a systematic review.

Authors:  Andrea Kleindienst; Francisco Marin Laut; Verena Roeckelein; Michael Buchfelder; Frank Dodoo-Schittko
Journal:  Acta Neurochir (Wien)       Date:  2020-08-20       Impact factor: 2.216

7.  A simple technique for thoracoscopic assisted placement of the distal limb of syringopleural shunts.

Authors:  Hugo Jr Bonatti; Khalid H Kurtom
Journal:  Respir Med Case Rep       Date:  2018-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.